In vivo fate and therapeutic efficacy of PF-4/CTF microspheres in an orthotopic human glioblastoma model

Ofra Benny, Seung Ki Kim, Koby Gvili, Inna S. Radzishevsky, Amram Mor, Luis Verduzco, Lata G. Menon, Peter M. Black, Marcelle Machluf*, Rona S. Carroll

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

36 Scopus citations


The correlation between glioma grade and angiogenesis suggests that antiangiogenic therapies are potentially therapeutically effective for these tumors. However, to achieve tumor suppression, antiangiogenic therapies need to be administered daily using high systemic quantities. We designed a biodegradable polymeric device that overcomes those barriers by providing sustained local delivery of a C-terminal fragment of platelet factor 4 (PF-4/CTF), an antiangiogenic agent. Fluorescent-labeled microspheres composed of poly lactic-coglycolic acid (PLGA) were loaded with rhodamine-labeled PF-4/CTF and formulated to release their contents over time. Fluorescent labeling enabled the correlation between the in vitro to the in vivo kinetic and release studies. PF-4/CTF microspheres were injected into established intracranial human glioma tumors in nude mice. Noninvasive magnetic resonance imaging (MRI) was used to assess the therapeutic response. Tumor size, microvessel density, proliferation, and apoptosis rate were measured by histological analysis. Intracranially, the microspheres were located throughout the tumor bed and continuously released PF-4/CTF during the entire experimental period. MRI and histological studies showed that a single injection of microspheres containing PF-4/CTF caused a 65.2% and 72% reduction in tumor volume, respectively, with a significant decrease in angiogenesis and an increase in apoptosis. Our data demonstrate that polymeric microspheres are an effective therapeutic approach for delivering antiangiogenic agents that result in the inhibition of glioma tumor growth.

Original languageAmerican English
Pages (from-to)488-499
Number of pages12
JournalFASEB Journal
Issue number2
StatePublished - Feb 2008
Externally publishedYes

Bibliographical note

Funding Information:
Funding: The research was supported by grants from the National Natural Science Foundation of China (No.61372034).


  • Angiogenesis
  • Brain tumor
  • Local delivery
  • PLGA


Dive into the research topics of 'In vivo fate and therapeutic efficacy of PF-4/CTF microspheres in an orthotopic human glioblastoma model'. Together they form a unique fingerprint.

Cite this